APRI : Summary for Apricus Biosciences, Inc. - Yahoo Finance

U.S. Markets closed

Apricus Biosciences, Inc. (APRI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.14-0.06 (-5.00%)
At close: 4:00 PM EST
People also watch:
ANTHBIODCPRXATOSALIM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.20
Open1.16
Bid1.03 x 200
Ask2.04 x 4900
Day's Range1.14 - 1.23
52 Week Range0.26 - 2.98
Volume117,042
Avg. Volume451,648
Market Cap8.82M
Beta-0.62
PE Ratio (TTM)-0.70
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks22 hours ago

    5 Efficient Stocks to Buy for Superlative Returns

    Investors seeking impressive returns irrespective of market conditions may consider adding stocks with favorable efficiency levels to their portfolios.

  • GlobeNewswire9 days ago

    Apricus Biosciences Receives Nasdaq Compliance Notice

    Company Intends to Request Hearing SAN DIEGO, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, ...

  • GlobeNewswire9 days ago

    Apricus Biosciences Receives Nasdaq Compliance Notice

    SAN DIEGO, Dec. 01, 2016-- Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that on November 30, 2016, the Company received ...